Adele M. Gulfo - 15 Apr 2025 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Reporting relationship
Director
Issuer ticker
NAMS
Reported as of
15 Apr 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
17 Apr 2025, 17:34:19 UTC
Prior SEC filing
01 Apr 2025
Next SEC filing
20 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Louise Kooij by Power of Attorney from Adele Gulfo

Key filing fact

Adele M. Gulfo filed Form 3 for NewAmsterdam Pharma Co N.V. (NAMS) on 17 Apr 2025.

Key facts

  • This page summarizes Adele M. Gulfo's Form 3 filing for NewAmsterdam Pharma Co N.V. (NAMS).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Apr 2025, 17:34.

Change

  • Previous filing in this sequence was filed on 01 Apr 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

SEC remarks

Exhibit List: Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .